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Background: Current echo contrast agents, including agitated saline, have limitations. We developed a microbubble contrast agent comprised 
solely of oxygen and normal saline (NS), based on a novel surfactant-free generation method termed Controlled Nucleation from Gas Supersaturated 
Solutions (CNSS).
purpose: To study the effect of [O2] on mean bubble diameter (D) and density (ρ); and on echo contrast t1/2 in vitro and in vivo in anesthetized 
swine.
Methods: Light microscopic images of the CNSS effluent were recorded with a digital video camera during 20 nanosecond strobe light exposures. 
D and ρ were quantified with Motic video software. Videodensitometry of echo contrast was performed for measurement of t1/2 .
results: As [O2] increased from 0.2 to 1.2 mL O2/mL, mean D increased from 11 ± 4.6 to 13 ± 5.7(r=0.22) µm, while mean ρ increased from 
(3.8 ± 1.9) x 106/mL to (32 ± 6) x106/mL NS (r=0.95). Echo contrast t1/2 was 12 -15 sec in vitro and < 10 s in vivo, values significantly shorter (p 
< .05) than those of agitated saline boluses (20-40 sec in vitro and in vivo). No adverse hemodynamic effects were noted in vivo during prolonged 
(1- 10 min) right heart infusions of CNSS echo contrast.
conclusions: CNSS generates remarkably small oxygen microbubbles with a high, predictable bubble density. The inherent biocompatibility, short 
half-life, and potential for prolonged infusions confer potential advantages of the CNSS effluent as an echo contrast agent.
